425: Strive CRO Reposts Semler Scientific Merger Update

Strive's Chief Risk Officer reposted a communication detailing the proposed business combination with Semler Scientific, emphasizing forward-looking statements and regulatory filing requirements.

Summary

• Strive, Inc. and Semler Scientific, Inc. are pursuing a proposed business combination.
• The communication, reposted by Strive's Chief Risk Officer Jeff Walton on September 22, 2025, serves as a cautionary statement regarding forward-looking information.
• It outlines the process for regulatory filings, including Strive's intent to file a Registration Statement on Form S-4, which will include an Information Statement/Proxy Statement/Prospectus.
• Stockholders of Semler Scientific will receive the Information Statement/Proxy Statement/Prospectus to seek their approval of the proposed transaction.
• Investors are urged to read all relevant SEC filings before making voting or investment decisions.

Sentiment

Score: 5

Explanation: The filing is primarily a procedural and cautionary statement regarding a proposed merger, outlining numerous risks without providing new financial performance data or definitive positive updates. The tone is neutral, but the extensive risk disclosure leans it slightly away from purely positive.

Positives

• The proposed transaction aims for strategic and financial benefits for the combined company.

Negatives

• The communication highlights numerous risks and uncertainties that could cause actual results to differ materially from anticipated outcomes.
• Potential for the proposed transaction to be more difficult, time-consuming, or costly than expected.
• Risk of dilution for Strive's Class A common stock holders due to the issuance of additional shares for the transaction.

Risks

• Occurrence of any event, change, or circumstance that could lead to termination of the merger agreement.
• Possibility that the proposed transaction does not close when expected or at all due to unfulfilled conditions.
• Outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company.
• Anticipated benefits (cost savings, strategic gains) may not be realized, including risks from Bitcoin treasury strategies and digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, and regulatory changes.
• Integration of the two companies may be more difficult, time-consuming, or costly than expected.
• Proposed transaction may be more expensive or take longer to complete than anticipated.
• Diversion of management's attention from ongoing business operations.
• Dilution caused by Strive's issuance of additional Class A common stock.
• Potential adverse reactions from customers or changes to business/employee relationships.
• Changes in Strive's or Semler Scientific's share price before closing.
• Other unknown or unpredictable factors could harm the combined company's results.

Future Outlook

The outlook includes expectations for the proposed transaction, anticipated strategic and financial benefits, the timing of the closing, and the ability to successfully integrate the combined businesses. These are subject to inherent risks and uncertainties.

Management Comments

• Jeff Walton, Chief Risk Officer of Strive, Inc., reposted the communication on X.com.

Industry Context

The mention of "Bitcoin treasury strategies" and "risks associated with Bitcoin and other digital assets" suggests that the combined entity may be engaging with or expanding into the digital asset space, aligning with a broader trend of corporate adoption of cryptocurrencies as treasury assets or for strategic initiatives.

Legal Proceedings

• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company is identified as a risk.

Related Party Transactions

• Semler Scientific's definitive proxy statement for its 2025 Annual Meeting of Stockholders contains information on transactions with related persons.

Stakeholder Impact

• Potential adverse reactions from Strive's or Semler Scientific's customers.
• Changes to business or employee relationships.
• Dilution for Strive's Class A common stock holders.

Next Steps

• Strive intends to file a Registration Statement on Form S-4 with the SEC.
• The Registration Statement will include an Information Statement/Proxy Statement/Prospectus.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders to seek their approval of the proposed transaction.
• Investors and stockholders are urged to read the Registration Statement and Information Statement/Proxy Statement/Prospectus when they become available.

Key Dates

Recommendation

This filing is a standard regulatory communication (Form 425) related to a proposed business combination, primarily serving as a cautionary statement about forward-looking information and outlining the procedural steps for the merger. It does not provide new financial results or operational updates that would warrant a change in investment stance. The extensive list of risks associated with the merger, including integration challenges, potential non-realization of benefits, and market conditions, suggests a degree of uncertainty. Investors should hold their positions pending the filing of the definitive S-4 and Information Statement/Proxy Statement/Prospectus, which will contain more comprehensive details necessary for a thorough evaluation of the combined entity's prospects.

Keywords

Strive Inc., Semler Scientific Inc., Merger, Business Combination, SEC Filing, Form 425, Forward-Looking Statements, Bitcoin Treasury, Digital Assets, Corporate Governance, Risk Management